Evaluation of three chitin metal silicate co-precipitates as a potential multifunctional single excipient in tablet formulations

Marine Drugs

Volumn 8, Issue 5, 2010, Pages 1699-1715

  Hamid, Rana Al Shaikh ^a   Al Akayleh, Faisal ^a   Shubair, Mohammad ^a   Rashid, Iyad ^b   Remawi, Mayyas Al ^b   Badwan, Adnan ^b  

^a Petra University   (Jordan)

^b JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

Author keywords

Chitin metal silicate co precipitates; Direct compression; Multifunctional single tablet excipient; Wet granulation

Indexed keywords

CHITIN ALUMINUM SILICATE; CHITIN CALCIUM SILICATE; CHITIN MAGNESIUM SILICATE; CHITIN METAL SILICATE; DUMAZOLE; EXCIPIENT; FILLER; FLEXIMEX; IBUPROFEN; METRONIDAZOLE; MICROCRYSTALLINE CELLULOSE; SILICATE; SPIRONOLACTONE; UNCLASSIFIED DRUG; ALUMINUM SILICATE; CALCIUM DERIVATIVE; CALCIUM SILICATE; CHITIN; MAGNESIUM SILICATE; MAGNESIUM TRISILICATE; TABLET;

ARTICLE; CRUSHING STRENGTH; DENSITY; DRUG DESIGN; DRUG GRANULATION; DRUG SOLUBILITY; PRECIPITATION; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; CHEMISTRY; DRUG FORMULATION; EVALUATION STUDY; ISOLATION AND PURIFICATION; MEDICINAL CHEMISTRY; PROCEDURES; TABLET;

ALUMINUM SILICATES; CALCIUM COMPOUNDS; CHEMICAL PRECIPITATION; CHEMISTRY, PHARMACEUTICAL; CHITIN; DRUG COMPOUNDING; EXCIPIENTS; IBUPROFEN; MAGNESIUM SILICATES; METRONIDAZOLE; SILICATES; SPIRONOLACTONE; TABLETS;

EID: 77953005420     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md8051699     Document Type: Article

References (22)

1. Silverstein, I. Excipient GMP Quality Standards One Is Enough. Pharm. Technol. 2002, 25, 46-52.
2. Armstrong, N.A. Functionality Related Tests for Excipients. Int. J. Pharm. 1997, 155, 1-5.
3. Van de Waterbeemd, H; Testa, B. Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability, 2nd ed.; Wiley-VCH: New York, NY, USA, 2008.
4. Jackson, K.; Young, D.; Pant, S. Drug-excipient interactions and their affect on absorption. Pharm. Sci. Technol. Today 2000, 3, 336-345.
5. Monedero Perales, M.C.; Munoz-Ruiz, A.; Velasco Antequera, M.V.; Munoz Munoz, N.; Jimenez-Castellanos, M.R. Comparative Tableting and Microstructural Properties of a New Starch for Direct Compression. Drug Develop. Ind. Pharm. 1996, 22, 689-695.
6. Hwang, R.; Peck, G.R. A Systematic Evaluation of the Compression and Tablets Characteristics of Various Types of Microcrystalline Cellulose. Pharm. Technol. 2001, 24, 112-132.
7. Reimerdes, D.; Aufmuth, K.P. Tabletting with Co-processed Lactose-Cellulose Excipients. Manuf. Chem. 1992, 63, 21-24.
8. Lourdes Garzo'n, M.; Villafuerte, L. Compactibility of mixtures of calcium carbonate and microcrystalline cellulose. Int. J. Pharm. 2002, 231, 33-41.
9. Patel, V.; Patel, M.; Patel, R. Chitosan: A Unique Pharmaceutical Excipient. Drug Deliv. Technol. 2005, 6, 30-40.
10. El-Barghouthi, M.; Eftaiha, A.; Rashid, I.; Al-Remawi, M.; Badwan, A. A Novel Superdisintegrating Agent Made from Physically Modified Chitosan with Silicon Dioxide. Drug Develop. Ind. Pharm. 2008, 34, 373-383.
11. Rashid, I.; Al-Remawi, M.; Eftaiha, A.; Badwan, A. Chitin silicone dioxide coprecipitate as a novel superdisintegrant. J. Pharm. Sci. 2008, 97, 4955-4969.
12. Rashid, I.; Daraghmeh,N.; Al-Remawi, M.; Leharne, S.; Chowdhry, B.; Badwan, A. Characterization of Chitin-Metal Silicates as Binding Superdisintegrants. J. Pharm. Sci. 2009, 98, 4887-4901.
13. Mura, P.; Manderioli, A.; Bramanti, G.; Furlanetto, S.; Pinzauti S. Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients. Int. J. Pharm. 1995, 119, 71-79.
14. Verma, R.; Garg, S. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing. J. Pharmceut. Biomed. 2005, 38, 633-644.
15. Martins, E.; Christiana, I.; Olobayo, K. Effect of Grewia gum on the mechanical properties of Paracetamol tablet formulations. Afr. J. Pharm. Pharmaco. 2008, 2, 001-006.
16. Odeku, O.A.; Patani B.O. Evaluation of dika nut mucilage (Irvingia gabonensis) as binding agent in metronidazole tablet formulations. Pharm. Develop. Technol. 2005, 10, 439-446.
17. Gohel, M.C.; Parikh, R.K.; Brahmbhatt, B.K.; Shah, A.R. Improving the tablet characteristics and Dissolution Profile of Ibuprofen by Using a Novel Coprocessed Superdisintegrant. AAPS PharmSciTech. 2007, 8, Article 13.
18. Medina, M.R.; Kumar, V. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations. Int. J. Pharm. 2006, 322, 31-35.
19. RxList. The Internet Drug Index. Aldactone®, (spironolactone) Tablets, USP, 2008; pp. 1-8.
20. Paronen, P.; Iilla, J. Porosity-Pressure Functions. Pharmaceutical Powder Compaction Technology; Marcel Dekker Inc.: New York, NY, USA, 1996; pp. 55-75.
21. Itiola, O.A. Compressional characteristics of three starches and the mechanical properties of their tablets. Pharm. World J. 1991, 8, 91-94.
22. Kawakita, K.; Ludde, K.H. Some considerations on powder compression equations. Powder Technol. 1971, 4, 61-68.